Observational Study of Management and Outcomes in Patients with Dermatologic Diseases Including Vitiligo, Atopic Dermatitis, Alopecia Areata, and Hidradenitis Suppurativa

What this Trial Is About

Researchers are conducting TARGET-DERM, an observational study to review outcomes for patients with various dermatologic diseases DD and the healthcare providers who treat them. This study involves patients with DD of any cause receiving usual care in the United States. It aims to answer important clinical questions about managing dermatologic conditions by gathering and analyzing data from both academic and community medical settings. The study collects real-world data from patients diagnosed with DD and providers managing these conditions to build a comprehensive database. It includes patients across different age groups and diagnoses, such as vitiligo, atopic dermatitis, alopecia areata, and hidradenitis suppurativa. The research also seeks to develop learning health networks focused on improving the quality of care for patients with these skin diseases. Participants provide informed consent and may be involved in activities such as data collection from electronic health records and patient-reported outcomes over a period of up to 15 years. Researchers will assess treatment safety and effectiveness, characterize the natural history of dermatologic diseases, and evaluate provider management practices. The study also monitors longitudinal outcomes to support improvements in patient care and health networks.

An Observational Study of Patients With Dermatologic Disease